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Abstract
Background: Apple polyphenols could represent a novel nutritional approach in the management and control of
blood glucose, especially in type 2 diabetics. The aim of this study was to test the therapeutic potential of an apple
polyphenol extract (APE) in an insulin-resistant rat model and to determine the molecular basis of insulin sensitivity
action in skeletal muscle cells.
Methods: Acute effect of APE on the postprandial hyperglycemic response was assayed in 15 week old obese
Zucker rats (OZR), by using a meal tolerance test (MTT). The ability of APE to improve whole peripheral insulin
sensitivity was also assayed in a chronic study by using the euglycemic-hyperinsulinemic clamp technique. To
elucidate the molecular mechanisms, rat L6 myotubes were used. Glucose uptake was measured by using 2-[3H]-
Deoxy-Glucose (2-DG) and specific inhibitors, as well as phosphorylation status of key kinases, were used to
determine the implicated signaling pathway.
Results: In vivo study showed that nutritional intervention with APE induced an increase of insulin sensitivity with
an increase of glucose infusion rate (GIR) of 45 %. Additionally, in vitro results showed a synergistic effect between
APE and insulin as well as increased glucose uptake through GLUT4 translocation in muscle cells. This translocation
was mediated by phosphatydil inositol 3-kinase (PI3K) and peroxisome proliferator-activated receptor-gamma
(PPARγ) signaling pathways.
Conclusions: As a whole, this study describes the mechanisms involved in the insulin sensitizing effect of APE,
which could be considered a promising ingredient for inclusion in nutritional products focused on the
management of chronic diseases such as diabetes.
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Background
Diabetes, in particular type 2 diabetes, is one of the major
worldwide health problems. To avoid the increasing
prevalence of diabetes, it is imperative to focus on the pre-
vention of insulin resistance, which precedes the onset of
diabetes. During this stage, different approaches have fo-
cused on lowering intestinal carbohydrate digestion and
absorption through the inhibition of α-amylase and α-
glucosidase, increasing insulin secretion and glucose tissue
disposal (insulin sensitizing agents) and decreasing hepatic
glucose production through the inhibition of gluconeo-
genesis and glycogenolysis in the liver [1, 2]. In this frame-
work, nutritional dietary components have performed well
in clinical practice and are showing optimal results in the
prevention of diabetes progression.
Among dietary components that could exert a positive
and beneficial effect in the control of blood glucose,
fruits and vegetables have shown promising results. In-
deed, epidemiological evidence suggests that a diet rich
in fruits and vegetables may decrease the risk of chronic
diseases such as cardiovascular disease and diabetes [3].
Moreover, interventional clinical trials support the role
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of polyphenols, flavonoids and carotenoid [4] rich foods
in the prevention of chronic diseases associated with
oxidative stress such as type 2 diabetes.
Apples are one of the most consumed sources of poly-
phenols in the Western diet containing mainly quer-
cetin, catechin, proanthocyanidin, gallic acid, phloridzin
and chlorogenic acid [5]. Apple polyphenols have shown
strong antioxidant activity [6], anti-carcenogenic effects
[7] and a high capacity to reduce lipid oxidation [8], as
well as hipocholesterolemic effects [9]. Regarding the
potential antidiabetic effects of apple polyphenols, high
intake of quercetin, chlorogenic acid and phloridzin has
been associated with reduced postprandial hypergly-
cemia primarily by inhibiting intestinal glucose absorp-
tion [10]. Glucose is absorbed by the intestine mainly
through sodium-glucose linked transporter 1 (SGLT1) and
glucose transporter 2 (GLUT2) [11]. Many phenolic com-
pounds, including apple polyphenols, have shown the abil-
ity to inhibit these transporters. In addition to inhibition
of glucose transport, these polyphenols also have the
ability to directly inhibit enzymes responsible for the
hydrolysis of carbohydrates at intestinal level (α-amylase
and α-glucosidase) [10], further reducing intestinal glu-
cose absorption.
However, the potential effects of muscle insulin sensitiv-
ity associated with apple polyphenols remains unknown.
Therefore, the present study was designed to evaluate the
effect of an apple polyphenol extract (APE) on insulin sen-
sitivity in obese Zucker fatty fa/fa rats (OZR, an insulin re-
sistant model) as a novel antihyperglycemic mechanism to
counteract diabetes progression. Moreover, the molecular
basis of the insulin sensitivity action of APE in cultured
skeletal muscle cells as an insulin-responsive model was
also evaluated. Our results show that the antihyperglyce-
mic effects of APE are mediated not only by inhibiting in-
testinal glucose absorption but also by stimulating muscle
insulin sensitivity through a mechanism that involves in-
creased expression of glucose transport proteins.
Methods
Evaluation of the antidiabetic effect of APE in OZR
Animals
Fourteen week old, obese male OZR were obtained from
Charles Rivers Laboratories (Orleans Cedex, France). They
were individually housed under a 12-h cycle of light and
dark at 21 °C. All experimental procedures were carried
out according to the ethical guidelines for animal experi-
mentation provided by the Spanish National Research
Council (RD 1201/2005 October 10).
Acute effect of APE on the postprandial glycemic response
during the time course of a Meal Tolerance Test (MTT)
Twenty rats were assigned into two groups: Control
(n = 10) and APE groups (n = 10). The control group
was orally treated with a solution containing maltodextrin
(MD, DE 21.5, Cerestar, Spain) at the dose of 1 g/kg body
weight (bw). The APE group was given an oral dose of
MD containing APE at the dose of 150 mg APE/kg bw.
APE was purchased from Exxentia (Spain) and the poly-
phenolic concentration of this extract was 57.5 %, under-
scoring the amount of phloridzin (9.9 %), chlorogenic acid
(15.8 %) and quercetin (0.4 %). Blood samples were ob-
tained via tail vein at baseline and at 30, 60, 90 and
120 min postprandial for glucose and insulin analysis.
In order to investigate the second-meal effect after the
ingestion of APE at breakfast, a second meal tolerance test
was performed by administering only MD at the dose of
1 g/kg bw after 270 min from the first gavage. Blood sam-
ples were also collected at baseline and 30, 60, 90, 120,
180 and 240 min for glucose and insulin analysis.
Ex-vivo α-glucosidase activity of APE
α-glucosidase inhibitory properties of APE were assayed
in intestinal mucosa isolated from OZR following Dahlqvist
methodology [12]. Maltase, isomaltase and sucrase activities
were determined using maltose, isomaltose and sucrose as
substrates. Results were expressed as the concentration of
APE required to achieve 50 % of inhibition (IC50).
Chronic effect of APE extract on insulin sensitivity
The effect of APE on whole body insulin sensitivity was
performed on 15 week old OZR. Twenty OZR were
weighed and divided into two experimental groups
(Control and APE) of ten animals. The control group re-
ceived the standard purified rodent diet (AIN-93 M)
[13] ad libitum for five weeks. The APE group received
the standard diet supplemented with APE (3 g/kg diet)
during the same period. Individual body weights were
recorded at the beginning of the study and at weekly in-
tervals thereafter. The food consumption of each rat was
determined twice per week.
Four weeks prior to the end of the feeding study, an
additional MTT assay was performed on both study
groups using MD in fasting conditions.
The insulin sensitizing effect of APE was determined one
week later using a modified euglycemic-hyperinsulinemic
clamp technique developed by De Fronzo et al. [14]. In
brief, overnight-fasted rats were anesthetized with sodium
pentobarbital (50 mg/kg bw) (Pentothal, Abbott Laborator-
ies, Madrid, Spain). Two catheters were placed in the right
jugular vein for insulin and glucose infusion. Another cath-
eter was placed in the left carotid artery for blood sam-
pling. A tracheotomy was performed to allow for tracheal
clearing. After approximately 40 min of surgery, arterial
blood samples were collected for determination of glucose
and insulin basal concentrations. At time 0, human insulin
(Humulin R; Eli Lilly,Indianapolis, IN) was infused at a
concentration of 15 mU/kg per minute. Blood samples
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were subsequently drawn at five-minute intervals for deter-
mination of blood glucose (Precision G Medisense,
Bedford, Massachusetts, USA). An infusion of 30 % glucose
was adjusted to maintain blood glucose at 100 mg/dL.
Steady state was ascertained when a fixed glucose infusion
rate (GIR) maintained blood glucose measurements con-
stant for at least 30 min.
Analytical procedures
Blood glucose was determined using Precision PCx glucose
meter equipment (Abbott Laboratories). Serum insulin
concentration was measured by enzyme immunoassay
(Mercodia AB, Uppsala, Sweden) using rat insulin as stand-
ard. Serum biochemical markers were determined using an
Alcyon C-3500 autoanalyzer (Abbott Laboratories).
Evaluation of the insulin sensitivity mechanisms of APE in
L6 myotubes
Cell culture
L6.C11 rat skeletal muscle myoblast line (ECACC n°
92102119) and CHO-k1 (ATCC no. CCL-61) cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10 % (v/v) fetal bovine serum (FBS), 2 mM
glutamine plus 100 units/mL penicillin and 0.1 mg/mL
streptomycin (Sigma, St. Louis, MO, USA) in an atmos-
phere of air/CO2 (95:5) and maintained at subconfluent
densities in growth media. L6 myoblasts were differenti-
ated into myotubes by exchanging the growth medium
with a differentiation medium consisting of DMEM con-
taining 2 % (v/v) fetal bovine serum for 5–6 days (>50 %
fusion into multinucleated myotubes).
2-Deoxy-[3H]D-glucose (2-DG) uptake
Cells were grown in 48-well plates (Corning, NY, USA).
They were differentiated into myotubes and then incubated
in serum-free medium for 18–21 h. Treatments were per-
formed in serum-free medium unless otherwise indicated.
Triplicate measurements of 2-DG (Perkin Elmer, Waltham,
MA, USA) uptake were taken after 10 min of incubation
following the method described by Yonemitsu et al. [15].
Subcellular fractionation
Membrane fractions from myotubes were prepared as de-
scribed [15, 16]. 5′-nucleotidase and cytochrome c reduc-
tase activities were assayed as marker enzymes for plasma
membranes and low-density microsomes, respectively [17].
Glucose transporter 4 (GLUT4) protein analyses
L6 myotubes membrane fraction proteins were electro-
phoresed in 10 % (w/v) SDS-PAGE and processed for
western blot with anti-GLUT4 antibodies (Biogenesis,
Poole, UK). Immunoreactive bands were visualized by
chemiluminescence and quantified with NIH Image
Software. Results were normalized with the band
intensity of actin (Developmental Studies Hybridoma
Bank, Iowa City, IA, USA) or caveolin-1 (Cell Signaling
Technology, Beverly, MA, USA).
Signaling pathways analyses
L6 myotubes were preincubated with different inhibitors
implicated in distinct signaling pathways leading to
GLUT4 translocation: wortmannin (100 nmol/L) (an in-
hibitor of the PI3K), PD 98059 (30 μmol/L) (an inhibitor
of the ERK1/2 phosphorylation) and GW9662 (10 μmol/L)
(an inhibitor of PPARγ). The inhibitors were added 30 min
before the incubation with APE (25 μg/mL) and main-
tained during the treatments (2 h).
Protein phosphorylation analysis were carried out as de-
scribed in [16]. Briefly, L6 myotubes were incubated in
FBS-free medium for 18–24 h and then treated with APE
(25 μg/mL) or rosiglitazone (10 μmol/L) in serum-free
medium. After treatment, plates were flash frozen in liquid
nitrogen and scraped with 50 μL/60 mm/plate of cold
30 mmol/L Tris-HCl pH 7.4, 25 mmol/L NaCl, 1 % (v/v)
Triton X-100, 0.1 % SDS, 10 mmol/L sodium fluoride,
10 mmol/L sodium pyrophosphate, 1 mmol/L sodium
orthovanadate, 1 mmol/L EGTA, 20 nmol/L okadaic acid,
10 μg/mL aprotinin, 10 μg/mL leupeptin, 10 μg/mL pep-
statin. After 10 min on ice, extracts were centrifuged at
13,000 ×g for 10 min at 4 °C. For the study of PPARγ ex-
pression, nuclear extracts were obtained in accordance
with Giron et al. 2008.
For the western blots analysis, proteins (25 μg) were
separated by SDS-PAGE and immunoblotted with anti-
bodies against PPAR-γ (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) and histone H3 (Epitomics, Burlingame,
CA, USA). The immunoblots were developed by chemi-
luminescence detection.
The expression plasmids pSV SPORT PPARγ1 and
pSV SPORT PPARγ2 and the PPAR responsive element-
driven luciferase reporter vector PPRE X3-TK-Luc PPRE
X3-TK-Luc were kindly provided by Dr. Bruce M.
Spiegelman (Dana-Farber Cancer Institute, Harvard Med-
ical School, Addgene plasmids 8886, 8862 and 1015).
CHO-k1 cells were transiently transfected with either pSV
SPORT PPARγ1 or pSV SPORT PPARγ2, the PPRE X3-
TK-Luc and the control plasmid pRL-TK. After 24 h, cells
were treated with rosiglitazone (10 μmol/L) or APE
(25 μg/mL) and cultured for 4 h in DMEM containing 2 %
(v/v) Charcoal/dextran stripped FBS (Sigma). The cells
were then used for dual luciferase reporter gene assay.
Statistical analyses
Data are presented as mean ± standard error of the mean
(SEM). In the case of the in vivo study, two-way re-
peated measurements ANOVA was used to analyze the
data for body weight, intake, glycemic and insulinemic
responses. A posteriori comparisons were done using the
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Bonferroni test. The remaining data was analyzed using
the unpaired Student t test. All statistical analyses were
performed using GraphPad 4.0 software.
Statistical analysis for in vitro studies was performed by
one way ANOVA followed by the Tukey test as appropri-
ate. P < 0.05 was considered statistically significant.
Results
Evaluation of the antidiabetic effect of APE in OZR
Acute effect of APE on the postprandial response
Figure 1 shows plasma glucose and serum insulin levels
following an oral meal challenge using MD in OZR. At
30 min post-gavage (Fig. 1a), the glucose concentration
was significantly lower in the group acutely administered
APE (150 mg/kg body weight) as compared to the group
treated only with MD (1 g/kg body weight). Incremental
area under curve (AUC) of glycemic response (Fig. 1b)
was also significantly lower after receiving APE as com-
pared with the group that only received MD. Nonetheless,
there were no differences in the insulinemic response be-
tween both groups (Fig. 1c and d).
Moreover, we investigated whether APE ingestion at
breakfast could improve glycemic and insulinemic re-
sponses after lunch, referred to as the second-meal effect.
The glycemic response after the second oral challenge
using only MD was higher than the responses ob-
tained after the first gavage in the two study groups
(Fig. 1e). Interestingly, the group that received APE in
the first MTT showed a decrease of 22 % in AUC for
glucose as compared with the control group (Fig. 1f ).
Ex-vivo α-glucosidase activity of APE
Dose-response curves of inhibitory activity of APE on intes-
tinal α-glucosidase activities were determined and the IC50
values were calculated. APE exhibited α-glucosidase inhibi-
tor action, with IC50 values for sucrase, maltase and
isomaltase enzymes of 18.05 ± 0.15 μg/mL, 14.18 ± 0.51 μg/
mL, and 12.54 ± 0.27 μg/mL, respectively.
Effects of APE on the regulation of insulin sensitivity
A chronic study was conducted to determine if APE




Fig. 1 Acute effects of APE (dose of 150 mg/kg bw) on the postprandial glycemic (a) and insulinemic (c) responses of maltodextrin in OZR and on the
respective areas under the curve (b, d). Acute effects of APE (dose of 150 mg/kg bw) on the second-meal effect. Blood glucose (e) and area under the
curve (f) after a first load of 150 mg APE/kg b.w. at 8:00 in the morning (simulating breakfast meal) and after a second load 1 g maltodextrin/kg bw
(simulating lunch meal) 5 h later. Results are expressed as mean ± SEM, n = 10 in each group. (a) p < 0.05 compared with control group
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mechanism involving regulation of insulin sensitivity, Rats
consuming a diet supplemented with APE (3 g extract/kg
diet) for five weeks showed similar body weight gain as
compared with rats consuming the control diet. There were
no additional differences in daily food intake (Table 1).
The postprandial glycemic and insulinemic responses
to a MD challenge (1 g/kg bw) after a chronic consump-
tion of APE (128 mg/kg bw) for four weeks are pre-
sented in Fig. 2. No significant differences were found
between both groups regarding fasting glucose in
plasma. As shown in Fig. 2a, absolute glucose levels at
30 min were lower in the APE group compared to the
AIN93M fed group. Incremental area under the curve
was significantly higher in the control group compared
to the APE group (Fig. 2b). After four weeks of treat-
ment, fasting insulin level was significantly lower in the
APE group with respect to the control group. In
addition, insulinemic response in the APE group was
significantly lower in the groups fed with the APE sup-
plemented diet as compared to the untreated group
(Fig. 2c and d) during the time course of the MTT.
Whole body tissue sensitivity to exogenous glucose was
determined in the steady-state period of the euglycemic
clamp, as expressed as glucose infusion rate (GIR) (Fig. 3).
The quantity of glucose required to establish euglycemia
during this period was affected by the diet. The GIR re-
quired to maintain euglycemia was significantly greater in
rats fed with APE as compared to the control diet. This
result signals that APE was able to stimulate glucose tissue
disposal as an insulin sensitizing agent.
Evaluation of the insulin sensitivity mechanisms of apple
polyphenols extract in L6 myotubes
Effect of APE on 2-DG uptake
The 2-DG assay was used to examine the effect of APE
on glucose uptake in L6-myotubes. A higher glucose up-
take was seen when myotubes were incubated for 18 h
with increasing amounts of APE (0–25 μg/mL). 2-DG
uptake was stimulated by APE, with a semi-maximal ac-
tivating concentration (EC50) of 4.2 ± 0.7 μg/mL and a
maximum relative increase in 2-DG uptake (Bmax) of
63.6 ± 2.3 % (Fig. 4a).
Next, to study if APE exerts any additive and/or syner-
gistic effect on insulin stimulated glucose uptake, L6
myotubes were incubated with APE (0–25 μg/mL), insu-
lin (50 nM) or both effectors for 18 h (Fig. 4b). The
results showed that 2-DG uptake was significantly stim-
ulated by APE in a dose dependent way. Additionally, in-
cubation of myotubes with both effectors (APE + insulin)
produced a synergistic effect on insulin-stimulated 2-DG
uptake as compared to either APE or insulin alone. This
synergistic effect appeared at a concentration of 5 μg/mL
of APE and rose with increasing concentrations of APE,
showing the highest effect at 25 μg/mL of APE.
Effect of APE on GLUT4 expression and translocation
Additionally, correlation between 2-DG uptake with
the expression of GLUT4 was studied. After incubat-
ing myotubes with 25 μg APE/mL for 18 h, the
amount of GLUT4 was quantified in total membranes
by Western blot using actin as a control. APE-treated
myotubes showed a similar content of GLUT4 to
control cells (Fig. 5a).
Following this, translocation of the transporter was
studied to determine if it might be a mechanism by
which APE increases muscle glucose uptake. Thus, L6
myotubes were incubated in absence or presence of
25 μg APE/mL for 18 h and GLUT4 protein concentra-
tion was determined in plasma membranes using
caveolin-1 as a loading control (Fig. 5a). Incubation with
APE significantly increased the amount of GLUT4 in the
plasma membrane fraction. Analysis of GLUT4 distribu-
tion in the different cellular membranes is the most
common technique used to determine GLUT4 trans-
location, the rate-limiting step for glucose uptake in
muscle [18]. Moreover, activation of GLUT4 transloca-
tion by 25 μg APE/mL was associated with a relative in-
crease of approximately 30 % in 2-DG uptake (Fig. 5b).
Signaling pathways modulated by APE in L6 myotubes
To gain insight into the mechanism of action involved in
the regulation of glucose uptake mediated by APE in
muscle cells, we studied how key components of the
PI3K-insulin, MAPK (ERK1/2) and PPARγ transduction
pathways are modulated by this compound.
The APE effects on glucose uptake were determined
using specific inhibitors of PI3K (wortmannin), ERK1/2
(PD98059) and PPARγ (GW9662). Both wortmannin
and GW9662 inhibited the increase of APE-mediated
glucose uptake compared to control cells while the
blockade of the ERK1/2 signaling pathway did not
change APE effects (Fig. 6a).
Table 1 Effect of APE supplementation on body weight, food
intake and metabolic parameters in fasting obese Zucker rats
Groups
Control APE
Initial body weight (g) 435.0 ± 8.2 436.6 ± 8.9
Final body weight (g) 473.9 ± 7.6 476.9 ± 8.9
Daily food intake (kcal) 66.03 ± 1.86 67.02 ± 1.19
Glucose (mg/dL whole blood) 181.2 ± 27.1 159.6 ± 8.5
Insulin (mU/L) 17.36 ± 1.64 11.23 ± 0.87a
Triglycerides (mg/dL) 482.1 ± 99.4 283.5 ± 24.7a
Total cholesterol (mg/dL) 219.1 ± 8.3 207.4 ± 4.3
LDL/HDL (ratio) 1.14 ± 0.09 1.07 ± 0.09
Values are means ± SEM, n = 10 in each group. (a) vs. Control group at p < 0.05
Manzano et al. Nutrition & Metabolism  (2016) 13:32 Page 5 of 10
To further confirm these results, the phosphorylation
of Akt after incubation with APE (25 μg/mL) or rosigli-
tazone (10 μmol/L) for 30 min was studied. As expected,
APE was able to significantly promote Akt phosphoryl-
ation, similar to results obtained with the specific inhibi-
tor wortmannin (Fig. 6b).
Since the PPARγ inhibitor GW9662 was able to block
the APE effects on glucose uptake, the PPARγ amount
in nuclear extracts was assayed after incubation with
APE (25 μg/mL) or rosiglitazone (10 μmol/L) for 30 min
(Fig. 6c). Predictably, rosiglitazone, a well known PPARγ
activator, induced an increase in the amount of protein
in the nucleus. A similar increase was obtained after in-
cubation with APE. To confirm the effects of APE on
PPARγ signaling, a reporter assay in CHO-k1 cells was
carried out. As indicated in Fig. 6d, incubation with APE
and rosiglitazone for 4 h significantly increased PPARγ
mediated transcription.
Discussion
Many fruits and vegetables have traditionally been used in
the treatment of diabetes, particularly those with elevated
concentrations of polyphenols [4]. In a Finish cohort study
[19] examining the association between flavonoid intake
and the risk of several chronic diseases, a reduced risk of
type 2 diabetes was associated with apple consumption.
Moreover, different studies have investigated the effects of
polyphenols describing their role in glucose absorption in
the gut. Nonetheless, although the potential antidiabetic
effect of APE has been previously reported, the molecular
mechanisms involved have not been totally elucidated.
The primary purpose of this study was to evaluate
whether the hypoglycemic action of apple polyphenols
could be mediated, not only by reducing the postpran-
dial glycemic response as consequence of the inhibition
of intestinal glucose absorption, but also by enhancing
muscle insulin sensitivity. The effects of APE in differen-
tiated L6 rat skeletal muscle cells were also evaluated in
order to elucidate the muscle insulin sensitivity mecha-
nisms. These cells have been widely used to investigate
the mechanism of insulin-stimulated glucose transport
[15, 20] and to gain insight into the related glucose up-
take signaling pathways [21].
The results of our study showed that acute administra-
tion of APE reduced the glycemic postpandrial response
a b
c d
Fig. 2 Chronic effects of APE on the postprandial glycemic (a) and insulinemic (c) responses of maltodextrin and respective areas under the
curve (b, d) in OZR fed with a standard rodent diet (AIN93M) supplemented with 3 g APE/kg diet for four weeks. Results are expressed as mean ± SEM,
n = 10 in each group. (a) p < 0.05 compared with control group
Fig. 3 Chronic effects of APE on whole-body insulin sensitivity in
OZR fed with a standard rodent diet (AIN93M) supplemented with
3 g APE/kg diet for five weeks. Results are expressed as mean ± SEM,
n = 10 in each group. (a) p < 0.05 compared with control cells
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as a consequence of the inhibition of intestinal glucosi-
dases activities. The extract assayed in this study pre-
sents a potent α-glucosidase inhibitory action. These
results are in agreement with other studies demonstrat-
ing that plant polyphenols play an important role in the
regulation of the activity of α-glucosidases. Moreover,
they agree with a study in which the antihyperglycemic
effects of polyphenols from different apple varieties
showed that apple polyphenols reduced intestinal glu-
cose absorption through the inhibition of α-glucosidase
activities [22].
In addition to the immediate acute effect, APE was eval-
uated for the second-meal effect on the postprandial gly-
cemic response. The second-meal effect is a parameter
commonly evaluated in studies involving natural ingredi-
ents or products in order to assess the influence of these
compounds over the glycemic response of subsequent
meals [23, 24]. In this study, APE administration at the
first meal (breakfast) produced a reduction of over
22 % in the glucose response after an oral administra-
tion of maltodextrin that simulated a lunch meal, as
compared to the control group. The exact mechanism
underlying the second-meal effect has yet to be under-
stood and could be related to several mechanisms. In-
dependent of the factors possibly influencing the second-
meal effect, insulin sensitivity common improves, especially
when the duration of the second-meal effect is not long,
e.g. from breakfast to lunch [25].
In order to determine the potential insulin sensitivity
effect of APE, the long term effects of APE intake
(128 mg/kg bw) were also evaluated after 4 weeks of
treatment. Animals that had received APE in fasting
conditions showed lower glucose and insulin levels than
the control group. Additionally, they had reduced gly-
cemic and insulinemic responses after a challenge with
MD (1 g/kg bw). These results are in agreement with
another study which used a different model of diet-
induced obesity in Wistar rats that were fed apple
polyphenols for 8 weeks at the dose of 700 mg/kg bw
[26]. In this study, the administration of APE improved
glucose tolerance and protected against body weight gain
and fat deposition in the rats. The authors of this study
suggested that the effects of APE were exerted through
the regulation of adipogenesis, lipolysis and fatty acid
oxidation. However, based on our results we also suggest
that APE may improve glucose tolerance through the
stimulation of insulin sensitivity. To prove this hypoth-
esis, insulin sensitivity was evaluated by the euglycemic
a
b
Fig. 4 Effects of APE on 2-deoxy-glucose uptake. a L6 myotubes were
deprived of FBS for 18 h and then incubated with increasing amounts of
APE (0–25 μg/mL) for 18 h. b L6 myotubes were incubated with APE
(1–25 μg/mL) in the absence or presence of 50 nmol/L insulin for 18 h.
Results are mean ± SEM of five independent experiments. (a) p< 0.05
compared with untreated cells. (b) p< 0.05 compared with cells treated
with insulin. Black bars and white bars indicate absence or presence of
insulin. Patterned bar indicates synergistic effect of insulin and APE
a
b
Fig. 5 Effects of APE on GLUT4 protein levels in L6 myotubes. a Cells
were deprived of FBS for 18 h and incubated in the absence or presence
of 25 μg/mL APE for 18 h. GLUT4 protein amount was assayed by
Western blot in cell lysates and plasma membrane fractions. Signal
densities from control cells were assigned a value of 100 % for the
transporter. Effects of APE on 2-DG uptake. b L6 myotubes were
deprived of FBS for 18 h and then incubated with increasing amounts of
APE (0–50 μg/mL) for 2 h. Results are mean ± SEM of five independent
experiments. (a) p< 0.05 compared with control non-treated cells
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clamp technique, which is considered the “gold stand-
ard” for assessing whole body insulin sensitivity. Our re-
sults showed that the 5-week nutritional intervention
with APE induced an increase in GIR of 45 %, which is
indicative of a better ability of the peripheral tissues to
respond to glucose uptake upon insulin stimulation.
At present, it is known that impaired insulin sensi-
tivity and increased insulin resistance are profoundly
involved in the progression of type 2 diabetes; and
therapies improving or enhancing insulin sensitivity
are being sought.
Subsequently, the next step was to investigate the
underlying mechanism involved in the stimulation of in-
sulin sensitivity with special focus on muscle as the main
tissue responsible for global insulin sensitivity [27].
APE was able to stimulate glucose uptake in L6 myo-
tubes after 18 h of incubation. This effect was dose
dependent and additional APE showed a synergistic ef-
fect of insulin on glucose uptake. Therefore, treatment
with APE could enhance insulin action improving blood
glucose levels and preventing insulin resistance.
The increase of glucose uptake observed after incubat-
ing cells with APE might have been due to an enhance-
ment of the facilitated translocation of the GLUT4
transporter from the low density microsomes to the
plasma membrane by APE. It has been demonstrated
that translocation of the glucose transporter GLUT4 to
the plasma membrane is a prerequisite for the stimula-
tion of glucose uptake in muscle [20]. This is the first re-





Fig. 6 Analysis of APE effects on the signaling pathways involved in GLUT4 translocation in L6 myotubes. a Cells were pre-incubated with inhibitors of
PI3K (100 nmol/L wortmanin), ERK1/2 (30 μmol/L PD98059) and PPARγ (10 μmol/L GW9662) and then incubated in the absence or presence of
25 μg/mL APE for 2 h. Next, 2-DG uptake was determined. b, c L6 myotubes were deprived of FBS for 18 h and then incubated with 10 μmol/L
rosiglitazone (ROS) or 25 μg/mL APE for 30 min. Akt phosphorylation b in cell lysates, and PPARγ levels c in nuclear extracts were measured.
d CHO-k1 cells were deprived of FBS for 18 h and then incubated with 10 μmol/L ROS or 25 μg/mL APE for 4 h. PPARγ 1/2 mediated transcription was
measured. Results are expressed as mean ± SEM of five independent experiments. (a) p < 0.05 compared with control non-treated cells
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uptake mediated by APE promotes GLUT4 translocation
to the plasma membrane. The results provide evidence
that APE may improve hyperglycaemia in type 2 diabetes
because skeletal muscle is the major tissue responsible
for glucose uptake in response to insulin [28, 29].
Next, the analysis of the signaling pathways involved
in the increased GLUT4 translocation mediated by APE
was conducted using specific inhibitors. We found that
PI3K, a key kinase involved in muscle insulin signaling
[30], and PPARγ signaling pathways are responsible for
the increase in glucose uptake by APE in L6 myotubes.
On the one hand, it has been described that overexpres-
sion of PPARγ affects insulin sensitivity of skeletal
muscle cells, upregulating glucose uptake under insulin-
resistant conditions [31]. On the other hand, similar to
APE, other natural extracts, such as Salacia oblonga,
Artemisia princeps and Propolis extracts, have presented
an antihyperglycemic effect through activation of PI3K
and induction of GLUT4 translocation to the plasma
membrane in L6 myotubes [32–35].
The experiment using specific inhibitors of signaling
pathways suggested the involvement of the Akt and
PPARγ pathways in the effects of APE on glucose
homeostasis. Thus, the phosphorylation status of Akt
was determined in the presence of APE. Our results
confirm the involvement of this pathway. Furthermore,
western blot and reporter analysis also confirmed the in-
volvement of PPARγ signaling on APE positive effects.
In summary, using an in vitro model, we have shown
that APE improved glucose uptake in L6 myotubes
through a synergistic effect between APE and insulin
and an increase in the GLUT4 translocation. Taking into
account that GLUT4-dependent glucose transport in
skeletal muscle is likely the major mechanism for dietary
glucose disposal by skeletal muscle and the increased
GLUT4 at the cell surface is associated with an enhance-
ment of insulin sensitivity [36], these results signal that
APE could increase muscle-body insulin sensitivity.
Conclusions
In conclusion, APE exhibited an insulin sensitizing ef-
fect activating glucose transport through translocation
of GLUT4 mediated by PI3K and, PPARγ signaling
pathways in muscle cells. Considered together, APE
might emerge as a promising nutritional ingredient to
be considered for incorporation in nutritional prod-
ucts focused on the management of chronic diseases
such as diabetes.
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